MX2021001258A - Composicion topica. - Google Patents

Composicion topica.

Info

Publication number
MX2021001258A
MX2021001258A MX2021001258A MX2021001258A MX2021001258A MX 2021001258 A MX2021001258 A MX 2021001258A MX 2021001258 A MX2021001258 A MX 2021001258A MX 2021001258 A MX2021001258 A MX 2021001258A MX 2021001258 A MX2021001258 A MX 2021001258A
Authority
MX
Mexico
Prior art keywords
topical composition
composition
crisaborole
relates
present
Prior art date
Application number
MX2021001258A
Other languages
English (en)
Inventor
Nigel Crutchley
Original Assignee
Mc2 Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mc2 Therapeutics Ltd filed Critical Mc2 Therapeutics Ltd
Publication of MX2021001258A publication Critical patent/MX2021001258A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con una composición para aplicación tópica que comprende una fase acuosa continua, una fase oleosa líquida discontinua y crisaborol.
MX2021001258A 2018-07-31 2018-07-31 Composicion topica. MX2021001258A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2018/052191 WO2020025910A1 (en) 2018-07-31 2018-07-31 Topical composition

Publications (1)

Publication Number Publication Date
MX2021001258A true MX2021001258A (es) 2021-04-12

Family

ID=63294365

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001258A MX2021001258A (es) 2018-07-31 2018-07-31 Composicion topica.

Country Status (11)

Country Link
US (1) US20210275554A1 (es)
EP (1) EP3829538A1 (es)
JP (1) JP7268132B2 (es)
KR (1) KR20210039407A (es)
CN (1) CN112384201A (es)
AU (1) AU2018435421A1 (es)
BR (1) BR112020025884A2 (es)
CA (1) CA3105417A1 (es)
IL (1) IL280533A (es)
MX (1) MX2021001258A (es)
WO (1) WO2020025910A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201701583D0 (en) 2017-01-31 2017-03-15 Drug Delivery Solutions Ltd Topical composition
CN113712977A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种克立硼罗外用制剂其制备方法及用途
KR20230054682A (ko) * 2020-07-28 2023-04-25 아큐티스 바이오테라퓨틱스, 인크. Jak 저해제 및 라우레스-4를 함유하는 국소 제형

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
FR2710840B1 (fr) 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
CN1138515C (zh) 1996-03-08 2004-02-18 迪斯珀斯有限公司 包含一种油基双液体泡沫和一种水凝胶的分散体系
EP2343304B1 (en) * 2005-02-16 2015-06-10 Anacor Pharmaceuticals, Inc. Biocidal boronophthalide compounds
EP1988779B1 (en) * 2006-02-16 2015-06-24 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
EP1970047A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with a corticosteroid
JP5745279B2 (ja) * 2008-01-09 2015-07-08 アナコール ファーマシューティカルズ，インコーポレイテッド 抗炎症剤としてのホウ素含有小分子
BRPI0908565A2 (pt) * 2008-03-06 2017-05-23 Anacor Pharmaceuticals Inc composto, formulação farmacêutica, métodos para reduzir a liberação de uma citocina ou de uma quimiocina, para tratar uma condição em um animal e para inibir uma fosfodiesterase
NZ742208A (en) * 2015-11-30 2023-03-31 Anacor Pharmaceuticals Inc Topical pharmaceutical formulations for treating inflammatory-related conditions
WO2017102565A1 (en) * 2015-12-15 2017-06-22 Rita Dobmeyer Pharmaceutical composition comprising a fulvic acid and at least one boron-containing compound
WO2018013655A1 (en) * 2016-07-12 2018-01-18 Pliva Hrvatska D.O.O. Solid state forms of crisaborole
GB201701583D0 (en) * 2017-01-31 2017-03-15 Drug Delivery Solutions Ltd Topical composition

Also Published As

Publication number Publication date
AU2018435421A1 (en) 2021-01-07
WO2020025910A1 (en) 2020-02-06
CN112384201A (zh) 2021-02-19
KR20210039407A (ko) 2021-04-09
JP7268132B2 (ja) 2023-05-02
US20210275554A1 (en) 2021-09-09
JP2022501314A (ja) 2022-01-06
EP3829538A1 (en) 2021-06-09
CA3105417A1 (en) 2020-02-06
IL280533A (en) 2021-03-01
BR112020025884A2 (pt) 2021-03-23

Similar Documents

Publication Publication Date Title
MX2016014515A (es) Composicion topica de crema gel.
EP4257613A3 (en) Bispecific checkpoint inhibitor antibodies
AU2018258581A8 (en) RAF-degrading conjugate compounds
EA201992177A1 (ru) Композиции на основе нирапариба
MY186330A (en) Viscosifier for oil well fluids
UA115737C2 (uk) Інгібітор меланогенезу, який містить d-пантотеніловий спирт, і косметичний засіб для відбілювання шкіри, який містить такий інгібітор меланогенезу
WO2019098805A3 (ko) 폴리글리세릴계 유화제 및 소르비탄계 유화제를 포함하는 자외선 차단용 화장료 조성물
MX2022010755A (es) Inhibidores de quinasa y usos de los mismos.
MX2021001258A (es) Composicion topica.
GB2543186A (en) Diverter composition including rheologically modified invert emulsion
WO2018101663A3 (ko) 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법
EA201491689A1 (ru) Распыляемая композиция для местного применения и система для ее доставки
EA201890889A1 (ru) Композиция, содержащая ниацинамид и пиколинамид
MX2019010950A (es) Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso.
EA201790410A1 (ru) Содержащая цинеол композиция для назального применения
MX2019010367A (es) Formulacion acuosa de anticuerpo anti ligando 1 de muerte programada (pd-l1).
DK3844161T3 (da) Heteroaromatiske forbindelser som vanininhibitorer.
EA201890186A1 (ru) Применение штаммов микробактерий для получения антибактериальных агентов
EA032472B9 (ru) Композиция для укладки волос
EP3778842A4 (en) REFRIGERATOR, REFRIGERATOR OIL, WORKING LIQUID COMPOSITION FOR REFRIGERATOR
MX2019009036A (es) Composicion topica.
EA201791716A1 (ru) Фармацевтический состав
MX2017002015A (es) Ligando del receptor 2 de canabinoide radiomarcado.
PH12020551467A1 (en) Topical composition
MX2021004756A (es) Productos de consumo y sistemas de suministro que usan compuestos organolepticos.